Drug Type Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism 5-HT4 receptor modulators(Serotonin 4 (5-HT4) receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 26 May 2023 |